Search research articles
Contact Us
Filters
Showing results (71-80 of 222) with videos related to
Page
of 23
Sort By:
Science (New York, N.Y.)
|
May 28, 1976
Vasoactive intestinal polypeptide: abundant immunoreactivity in neural cell lines and normal nervous tissue
S I Said, R N Rosenberg
Annals of the New York Academy of Sciences
|
January 1, 1988
Vasoactive intestinal peptide as a regulator of exocrine function and as a possible factor in cystic fibrosis
P Heinz-Erian, S I Said
Regulatory Peptides
|
November 3, 1993
Vasoactive intestinal peptide and helodermin inhibit phospholipase A2 activity in vitro
M E Trotz, S I Said
Padiatrie Und Padologie
|
January 1, 1985
[Vasoactive intestinal polypeptide (VIP)--possible importance in diseases of childhood]
P Heinz-Erian, S I Said
The American Journal of Physiology
|
June 1, 1995
VIP inhibits basal and histamine-stimulated proliferation of human airway smooth muscle cells
K Maruno, A Absood, S I Said
Peptides
|
November 1, 1984
Purification of [125I]-vasoactive intestinal peptide by reverse-phase HPLC
S Paul, K Wood, S I Said
Science (New York, N.Y.)
|
December 12, 1980
Vasoactive intestinal peptide: a possible transmitter of nonadrenergic relaxation of guinea pig airways
Y Matsuzaki, Y Hamasaki, S I Said
Nihon Kyobu Shikkan Gakkai Zasshi
|
March 1, 1979
[Selective inhibition of hypoxic pulmonary vasoconstriction by inhibition of cytochrome oxidase (author's transl)]
N Hara, T Yoshida, S I Said
Bulletin Europeen De Physiopathologie Respiratoire
|
May 1, 1983
Platelet-activating factor increases pulmonary microvascular permeability and induces pulmonary edema. A preliminary report
M Mojarad, Y Hamasaki, S I Said
Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology
|
June 1, 1983
Relaxant action of VIP on cat pulmonary artery: comparison with acetylcholine, isoproterenol, and PGE1
Y Hamasaki, M Mojarad, S I Said
Page
of 23
Search research articles
Search
Showing results (71-80 of 222) with videos related to
Sort By:
Page
of 23
Science (New York, N.Y.)
|
May 28, 1976
Vasoactive intestinal polypeptide: abundant immunoreactivity in neural cell lines and normal nervous tissue
S I Said, R N Rosenberg
Annals of the New York Academy of Sciences
|
January 1, 1988
Vasoactive intestinal peptide as a regulator of exocrine function and as a possible factor in cystic fibrosis
P Heinz-Erian, S I Said
Regulatory Peptides
|
November 3, 1993
Vasoactive intestinal peptide and helodermin inhibit phospholipase A2 activity in vitro
M E Trotz, S I Said
Padiatrie Und Padologie
|
January 1, 1985
[Vasoactive intestinal polypeptide (VIP)--possible importance in diseases of childhood]
P Heinz-Erian, S I Said
The American Journal of Physiology
|
June 1, 1995
VIP inhibits basal and histamine-stimulated proliferation of human airway smooth muscle cells
K Maruno, A Absood, S I Said
Peptides
|
November 1, 1984
Purification of [125I]-vasoactive intestinal peptide by reverse-phase HPLC
S Paul, K Wood, S I Said
Science (New York, N.Y.)
|
December 12, 1980
Vasoactive intestinal peptide: a possible transmitter of nonadrenergic relaxation of guinea pig airways
Y Matsuzaki, Y Hamasaki, S I Said
Nihon Kyobu Shikkan Gakkai Zasshi
|
March 1, 1979
[Selective inhibition of hypoxic pulmonary vasoconstriction by inhibition of cytochrome oxidase (author's transl)]
N Hara, T Yoshida, S I Said
Bulletin Europeen De Physiopathologie Respiratoire
|
May 1, 1983
Platelet-activating factor increases pulmonary microvascular permeability and induces pulmonary edema. A preliminary report
M Mojarad, Y Hamasaki, S I Said
Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology
|
June 1, 1983
Relaxant action of VIP on cat pulmonary artery: comparison with acetylcholine, isoproterenol, and PGE1
Y Hamasaki, M Mojarad, S I Said
Page
of 23